Dozens of physician-scientists will share research insights at ASH 2024, a breast-cancer survivor chronicles her journey, researchers seek answers for gastric cancer disparities, and taking major steps to reduce lung cancer’s lethal burden are in this month tip sheet from Sylvester Comprehensive Cancer Center.
The University of Texas MD Anderson Cancer Center today was awarded nearly $8 million from the Cancer Prevention and Research Institute of Texas (CPRIT) in support of faculty recruitment as well as lung and colorectal cancer screening and early detection programs to address cancer incidence rates across Texas.
As a young man in his mid-20s, Jorge Gómez was one of thousands of Cuban citizens who fled Communism and the island country on a raft in 1994. He would spend 11 months living in a tent city at Guantanamo Bay before being granted asylum into the U.S., where he overcame countless obstacles to build a better life as an engineer and father of four boys. Patience, perseverance, and an eternal sense of optimism sustained him throughout his journey, he says. And it served him well in 2021 when, during a routine visit to his primary care physician, a cancerous growth in his esophagus was discovered. Heeding his doctor’s recommendation, he sought the help of Markus Goldschmiedt, M.D., Clinical Associate Professor of Internal Medicine at UT Southwestern Medical Center, who was building a reputation as one of only a handful of specialists in Dallas-Fort Worth who could offer a highly complex procedure known as endoscopic submucosal dissection (ESD).
Researchers at WashU Medicine shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut cancers.
A new study from researchers at The University of Texas MD Anderson Cancer Center finds that, in healthy women, some breast cells that otherwise appear normal may contain chromosome abnormalities typically associated with invasive breast cancer. The findings question conventional thinking on the genetic origins of breast cancer, which could influence early cancer detection methods. The study, published today in Nature, discovered that at least 3% of normal cells from breast tissue in 49 healthy women contain a gain or loss of chromosomes, a condition known as aneuploidy, and that they expand and accumulate with age. This poses questions for our understanding of “normal” tissues, according to principal investigator Nicholas Navin, Ph.D., chair of Systems Biology.
Roswell Park experts representing various specialties will highlight innovative research and advancements in hematology and hematologic cancers at the 66th annual meeting of the American Society of Hematology (ASH), to be held December 7-10 in San Diego, California.
Mutations in certain genes can lead to the accumulation of DNA errors, resulting in a specific type of genetic change known as large tandem duplications (TDs) that can arise from the collision of two critical cellular processes: transcription and DNA replication.
A group of investigators led by Cedars-Sinai have developed and successfully tested a new artificial intelligence (AI) method to make launching cancer clinical trials easier and faster.
Lung cancer is responsible for approximately 1 in 4 cancer deaths in the United States, making it the deadliest cancer among Americans. However, early detection and advancements in treatment can significantly improve patient outcomes.
Susan G. Komen commended the Massachusetts legislature for passing and Gov. Maura Healey for signing legislation that eliminates out-of-pocket expenses for diagnostic and supplemental breast imaging.
New research published in JAMA Network Open from Keck Medicine of USC, which includes USC Norris Comprehensive Cancer Center, suggests that among all cancer survivors, male adolescents or young adults (AYA) have the highest rate of death by suicide.
Pesquisadores da Mayo Clinic desenvolveram uma estratégia de testes inovadora para a mesotelioma que pode ser capaz de aumentar a taxa de detecção do DNA do câncer no sangue.
Investigadores de Mayo Clinic han desarrollado una estrategia de pruebas innovadoras para el mesotelioma que puede aumentar la tasa de detección del ADN del cáncer en la sangre.
Ryan Teague, Ph.D., professor of molecular microbiology and immunology at Saint Louis University’s School of Medicine, and his team are now trying to uncover the exact mechanism underlying the metabolic dysfunctions associated with obesity that directly impact T-cell function.
A new treatment approach developed at Roswell Park Comprehensive Cancer Center has shown promising results in a phase 1 clinical trial for patients with triple-negative breast cancer (TNBC), the most aggressive type of breast cancer. Results of the study are newly reported in The Journal for ImmunoTherapy of Cancer.
Mayo Clinic researchers have developed an innovative testing strategy for mesothelioma that could potentially increase the detection rate of cancer DNA in the blood.
How ecDNA Fuels Cancer by Breaking the Laws of Biology
New research sheds light on a surprising connection between COVID-19 and cancer regression
Showing results
1–1 of 1
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
